Pharmaceutical Product Supply – Nitroglycerin Ointment

The contract involves the manufacture and supply of Nitroglycerin Ointment, identified by NSN 6505010083401 and NDC 00281-0326-60, to meet all applicable FDA and U.S. military specifications. The product is intended for delivery to DLA Troop Support, ensuring it adheres to stringent quality, safety, and reliability standards required for military use. The work is classified under NAICS code 325412, indicating the production of pharmaceutical preparations, and is structured as a subcontract within the broader Defense Logistics Agency procurement framework. The contract was posted on August 9, 2026, and is associated with the DIBBS award record SPE2DX25D8022 and delivery order SPE2D926F8123. The ointment must be produced in compliance with federal regulations and military requirements, with no set-aside provisions specified, meaning the contract is open to any qualified manufacturer. Performance and delivery are expected to support the Department of Defense’s medical supply chain, with no specific location designated for performance but delivery targeted to DLA Troop Support operations. The contract is part of a long-term supply effort to maintain essential medical inventories for military personnel, emphasizing continuous availability and regulatory alignment. The details reflect a focus on standardized pharmaceutical manufacturing for critical defense logistics needs.